(a) General.
(1) Tolerances are established for the combined residues of pinoxaden (8-(2,6-diethyl-4-methylphenyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5] oxadiazepin-9-yl 2,2-dimethylpropanoate), and its metabolites 8-(2,6-diethyl-4-methyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepine-7,9-dione (M2), and free and conjugated forms of 8-(2,6-diethyl-4-hydroxymethyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5] oxadiazepine-7,9-dione (M4), and 4-(7,9-dioxo-hexahydro-pyrazolo[1,2-d] [1,4,5]oxadiazepin-8-yl)-3,5-diethyl-benzoic acid (M6), calculated as pinoxaden, in/on the following commodities:
| Commodity | Parts per million |
|---|---|
| Barley, bran | 1.6 |
| Barley, grain | 0.9 |
| Barley, hay | 1.5 |
| Barley, straw | 1.0 |
| Egg | 0.06 |
| Poultry, fat | 0.06 |
| Poultry, meat | 0.06 |
| Poultry, meat byproducts | 0.06 |
| Wheat, bran | 3.0 |
| Wheat, forage | 3.5 |
| Wheat, grain | 1.3 |
| Wheat, hay | 2.0 |
| Wheat, straw | 1.5 |
(2) For the combined residues of pinoxaden, 8-(2,6-diethyl-4-methylphenyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5] oxadiazepin-9-yl 2,2-dimethylpropanoate), and its metabolites M2, 8-(2,6-diethyl-4-methyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepine-7,9-dione, and free and conjugated forms of M4, 8-(2,6-diethyl-4-hydroxymethyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5] oxadiazepine-7,9-dione, calculated as pinoxaden, in/on the following commodities:
| Commodity | Parts per million |
|---|---|
| Cattle, fat | 0.04 |
| Cattle, meat | 0.04 |
| Cattle, meat byproducts | 0.04 |
| Milk | 0.02 |
(b) Section 18 emergency exemptions. [Reserved]
(c) Tolerances with regional registrations. [Reserved]
(d) Indirect or inadvertent residues. [Reserved]
[70 FR 43322, July 27, 2005]